BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19556086)

  • 1. [Cholestasis and cholestatic liver diseases].
    Poupon R
    Gastroenterol Clin Biol; 2009; 33(8-9):778-88. PubMed ID: 19556086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular mechanisms of bile formation and cholestatic diseases].
    Poupon R
    Bull Acad Natl Med; 2003; 187(7):1261-74; discussion 1274-6. PubMed ID: 15146603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biliary function and its regulation].
    Poupon R; Chignard N; Rosmorduc O; Barbu V; Housset C
    Med Sci (Paris); 2004 Dec; 20(12):1096-9. PubMed ID: 15581462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations.
    Zollner G; Marschall HU; Wagner M; Trauner M
    Mol Pharm; 2006; 3(3):231-51. PubMed ID: 16749856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholestatic liver diseases: slow progress in understanding and treating slowly progressive disorders.
    Vleggaar FP; Van Ooteghem NA; Van Buuren HR; Van Berge Henegouwen GP
    Scand J Gastroenterol Suppl; 2000; (232):86-92. PubMed ID: 11232499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular regulation of sinusoidal liver bile acid transporters during cholestasis.
    Gartung C; Matern S
    Yale J Biol Med; 1997; 70(4):355-63. PubMed ID: 9626756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular transport in acquired cholestasis: new insights into functional, regulatory and therapeutic aspects.
    Roma MG; Crocenzi FA; Sánchez Pozzi EA
    Clin Sci (Lond); 2008 May; 114(9):567-88. PubMed ID: 18377365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical treatment of cholestatic liver disease.
    Paumgartner G; Pusl T
    Clin Liver Dis; 2008 Feb; 12(1):53-80, viii. PubMed ID: 18242497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic disorders and molecular mechanisms in cholestatic liver disease--a clinical approach.
    Trauner M; Fickert P; Zollner G
    Semin Gastrointest Dis; 2001 Apr; 12(2):66-88. PubMed ID: 11352122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cholestatic liver diseases].
    Reichel C; Meier-Abt PJ
    Ther Umsch; 1997 Nov; 54(11):639-44. PubMed ID: 9454366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New molecular features of cholestatic diseases of the liver].
    Méndez-Sánchez N; Chavez-Tapia NC; Uribe M
    Rev Invest Clin; 2003; 55(5):546-56. PubMed ID: 14968476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cholestatic liver disease in children].
    Jankowska I; Pawłowska J; Swiatkowska E; Rujner J; Socha J
    Przegl Epidemiol; 2002; 56 Suppl 5():16-21. PubMed ID: 15553067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis.
    Beuers U
    Nat Clin Pract Gastroenterol Hepatol; 2006 Jun; 3(6):318-28. PubMed ID: 16741551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of cholestasis.
    Zollner G; Trauner M
    Wien Med Wochenschr; 2006 Jul; 156(13-14):380-5. PubMed ID: 16937039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis: a study of bile acid metabolism.
    Crosignani A; Podda M; Bertolini E; Battezzati PM; Zuin M; Setchell KD
    Hepatology; 1991 Jun; 13(6):1076-83. PubMed ID: 2050325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biliary physiology and disease: reflections of a physician-scientist.
    Paumgartner G
    Hepatology; 2010 Apr; 51(4):1095-106. PubMed ID: 20373364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New molecular insights into the mechanisms of cholestasis.
    Wagner M; Zollner G; Trauner M
    J Hepatol; 2009 Sep; 51(3):565-80. PubMed ID: 19595470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholestatic liver disease.
    Jüngst C; Lammert F
    Dig Dis; 2013; 31(1):152-4. PubMed ID: 23797137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathophysiology of cholestasis with special reference to primary biliary cirrhosis.
    Jansen PL
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):571-83. PubMed ID: 10976015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Regulation of hepatobiliary transporters in cholestatic liver disease].
    Geier A; Gartung C; Matern S
    Med Klin (Munich); 2004 Jan; 99(1):7-17. PubMed ID: 14716480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.